Hakon Leffler Selected Research

Hakon Leffler Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 01/2002
13	Inflammation (Inflammations) 01/2018 - 01/2002
8	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2003
6	Fibrosis (Cirrhosis) 06/2019 - 03/2012
6	Breast Neoplasms (Breast Cancer) 06/2018 - 06/2003
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 03/2012
2	Ulcerative Colitis 01/2016 - 08/2002
2	Hepatitis 02/2015 - 06/2012
2	Glomerulonephritis 09/2012 - 04/2012
2	Nephritis 09/2012 - 04/2012
2	Infections 04/2010 - 10/2002
1	Arthritis (Polyarthritis) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Corneal Neovascularization 01/2017
1	Burns 01/2017
1	Chronic Renal Insufficiency 01/2017
1	Disease Progression 02/2016
1	Stroke (Strokes) 03/2015
1	Synucleinopathies 11/2014
1	Asthma (Bronchial Asthma) 09/2012
1	Renal Insufficiency (Renal Failure) 04/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2012
1	Melanoma (Melanoma, Malignant) 12/2010
1	Papillary Thyroid Cancer 10/2009
1	Hyperplasia 04/2009
1	Prostatic Neoplasms (Prostate Cancer) 12/2008
1	Peripheral Nerve Injuries 05/2007

Drug/Important Bio-Agent (IBA)

25	Galectin 3 (LGALS3)IBA 01/2022 - 10/2002
17	Galectins (Galectin)IBA 01/2022 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
10	Galectin 1 (LGALS1)IBA 01/2018 - 07/2006
9	LectinsIBA 01/2022 - 05/2007
7	CarbohydratesIBA 01/2022 - 01/2004
6	Carrier Proteins (Binding Protein)IBA 12/2019 - 05/2005
5	LigandsIBA 08/2019 - 07/2006
4	Polysaccharides (Glycans)IBA 01/2022 - 01/2016
4	Galactose (Galactopyranose)FDA LinkGeneric 12/2019 - 03/2012
4	Galectin 4 (LGALS4)IBA 02/2016 - 01/2004
3	saccharide-binding proteinsIBA 11/2021 - 11/2014
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016 - 03/2012
3	Immunoglobulin A (IgA)IBA 09/2012 - 08/2002
3	Glycoproteins (Glycoprotein)IBA 09/2012 - 01/2011
3	DisaccharidesIBA 12/2010 - 07/2005
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
2	CateninsIBA 01/2021 - 03/2012
2	GalactosidesIBA 01/2018 - 04/2012
2	coumarinIBA 01/2018 - 01/2016
2	AntibodiesIBA 01/2016 - 08/2002
2	Biomarkers (Surrogate Marker)IBA 09/2012 - 01/2011
2	beta-galactosideIBA 04/2010 - 05/2005
2	Lactose FDA LinkGeneric 07/2006 - 07/2005
1	MucinsIBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Amyloid beta-PeptidesIBA 01/2019
1	citrus pectinIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	IonsIBA 06/2018
1	salinomycinIBA 06/2018
1	indolizineIBA 01/2018
1	quinolineIBA 01/2018
1	Silver NitrateIBA 01/2017
1	Connective Tissue Growth FactorIBA 01/2017
1	PectinsIBA 06/2016
1	pirfenidoneIBA 01/2016
1	Galectin 2 (LGALS2)IBA 01/2016
1	LipopolysaccharidesIBA 03/2015
1	Galactosylceramides (Galactocerebrosides)IBA 02/2015
1	GlycolipidsIBA 02/2015
1	SynucleinsIBA 11/2014
1	galactose-binding proteinIBA 07/2013
1	Tumor Biomarkers (Tumor Markers)IBA 09/2012
1	Blood Proteins (Serum Proteins)IBA 09/2012
1	EnzymesIBA 06/2012
1	Concanavalin AIBA 06/2012
1	CytokinesIBA 06/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2012
1	CollagenIBA 03/2012
1	Angiogenic ProteinsIBA 04/2011
1	HaptoglobinsIBA 01/2011
1	Immunoglobulin M (IgM)IBA 01/2011
1	GlycoconjugatesIBA 11/2010
1	SugarsIBA 11/2010
1	GlycosidesIBA 11/2010
1	Immunoglobulin D (IgD)IBA 04/2009
1	EstersIBA 12/2008
1	thiodigalactosideIBA 12/2008

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2003
2	Oral Administration 01/2019 - 01/2016
1	Cautery 01/2017
1	Drug Therapy (Chemotherapy) 10/2009